子查询返回的值不止一个。当子查询跟随在 =、!=、<、<=、>、>= 之后，或子查询用作表达式时，这种情况是不允许的。 NFAT2在非小细胞肺癌中的表达及预后关联研究-《天津医科大学学报》
|本期目录/Table of Contents|

[1]李晶鑫,许芳秀,王玉,等.NFAT2在非小细胞肺癌中的表达及预后关联研究[J].天津医科大学学报,2016,22(05):417-420.
　LI Jing-xin,XU Fang-xiu,WANG Yu,et al.Relationship between expression of NFAT2 and survival prognosis in? non-small cell lung cancer[J].Journal of Tianjin Medical University,2016,22(05):417-420.
点击复制

NFAT2在非小细胞肺癌中的表达及预后关联研究(PDF)
分享到：

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
22卷
期数:
2016年05期
页码:
417-420
栏目:
临床医学
出版日期:
2016-09-20

文章信息/Info

Title:
Relationship between expression of NFAT2 and survival prognosis in? non-small cell lung cancer
文章编号:
1006-8147（2016）05-0417-4
作者:
李晶鑫1; 许芳秀1; 2; 王玉1; 郭燕1; 3; 钱碧云1; 4
（1.天津医科大学肿瘤医院肿瘤流行病与生物统计室，国家肿瘤临床医学研究中心，天津市“肿瘤防治”重点实验室，天津300060；2.解放军第401 医院药剂科，青岛266071；3.天津医科大学肿瘤医院病理科，天津300060；4.上海交通大学公共卫生学院，上海200025）
Author(s):
LI Jing-xin1; XU Fang-xiu1; 2; WANG Yu1; GUO Yan1; 3; QIAN Bi-yun1; 4
关键词:
NFAT2; 非小细胞肺癌; 免疫组织化学技术
Keywords:
NFAT2;  non-small cell lung cancer;  immunohistochemistry
分类号:
R730.2
DOI:
-
文献标志码:
A
摘要:
目的：研究NFAT2在非小细胞肺癌（NSCLC）中的表达情况及与患者生存预后的关系。方法：收集原发性NSCLC肿瘤组织315例及其配对的正常组织164例，免疫组织化学染色检测NFAT2蛋白表达情况，同时进行临床关联及预后分析。结果：NFAT2在NSCLC中高表达（P<0.001）。在女性及非吸烟早期NSCLC中，NFAT2表达上调与生存期缩短相关，差异具有统计学意义（P=0.003、P=0.001）。结论：NFAT2是NSCLC发生的危险因子，NFAT2高表达可能预示着不良预后结局。
Abstract:
Objective: To study the relationship between the NFAT2 expression in non-small cell lung cancer (NSCLC) and the survival prognosis in NFAT2 and NSCLC. Methods: NFAT2 expression were detected by applying Immunohistochemistry in 315 NSCLC cancer tissues and 164 adjacent normal tissues. Then， the relationship between NFAT2 expression and survival prognosis was studied in NSCLC. Results: NFAT2 increased in NSCLC tumor tissues (P<0.001). The subgroup analysis showed that in the early NSCLC women and non-smokers, NFAT2 expression was significantly correlated with shortened survival (P=0.003, P=0.001). Conclusion: NFAT2 is a risk factor for NSCLC. NFAT2 high expression may indicate poor prognosis.

参考文献/References:

[1]Pakzad R, Mohammadian-Hafshejani A, Ghoncheh M, et al. The incidence and mortality of lung Cancer and their relationship to development in Asia[J].Translational lung cancer research,2015,4(6):763

[2]Hung J J, Jeng W J, Hsu W H, et al. Prognostic factors of postrecurrence survival in completely resected stage I non-small cell lung Cancer with distant metastasis[J].Thorax,2010,65(3):241

[3]Liu J F, Zhao S H, Wu S S. Depleting NFAT1 expression inhibits the ability of invasion and migration of human lung Cancer cells[J].Cancer Cell Int,2013,13(1):41

[4]Chen Z L, Zhao S H, Wang Z, et al. Expression and unique functions of four nuclear factor of activated T cells isoforms in non-small cell lung Cancer[J].Chin J Cancer,2011,30(1):62

[5]Fric J, Zelante T, Wong A Y, et al. NFAT control of innate immunity[J].Blood,2012,120(7):1380

[6]Marafioti T, Marafiot T, Pozzobon M, et al. The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas[J].Br J Haematol,2005,128(3):333

[7]Orhue V, Kanaji A, Caicedo M S, et al. Calcineurin/nuclear factor of activated T cells (NFAT) signaling in cobalt-chromium-molybdenum (CoCrMo) particles-induced tumor necrosis factor-α (TNFα) secretion in MLO-Y4 osteocytes[J].J Orthop Res,2011,29(12):1867

[8]Lawrence M C, Naziruddin B, Levy M F, et al. Calcineurin/nuclear factor of activated T cells and MAPK signaling induce TNF-{alpha} gene expression in pancreatic islet endocrine cells[J].J Biol Chem,2011,286(2):1025

[9]Zheng J, Fang F, Zeng X, et al. Negative cross talk between NFAT1 and Stat5 signaling in breast Cancer[J].Mol Endocrinol,2011,25(12):2054

[10]Perotti V, Baldassari P, Bersani I, et al. NFATc2 is a potential therapeutic target in human melanoma[J].J Invest Dermatol, 2012,132(11):2652

[11]Corral R S, I?iguez M A, Duque J, et al. Bombesin induces cyclooxygenase-2 expression through the activation of the nuclear factor of activated T cells and enhances cell migration in Caco-2 colon carcinoma cells[J].Oncogene,2007,26(7):958

[12]Robbs B K, Cruz A L, Werneck M B, et al. Dual roles for NFAT transcription factor genes as oncogenes and tumor suppressors[J].Mol Cell Biol,2008,28(23):7168

[13]Buchholz M, Schatz A, Wagner M, et al. Overexpression of c-myc in pancreatic Cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway[J].EMBO J,2006,25(15):3714

[14]Kawahara T, Kashiwagi E, Ide H, et al. The role of NFATc1 in prostate Cancer progression: cyclosporine A and tacrolimus inhibit cell proliferation, migration, and invasion[J].Prostate,2015,75(6):573

[15]Xu W, Gu J, Ren Q, et al. NFATC1 promotes cell growth and tumorigenesis in ovarian Cancer up-regulating c-Myc through ERK1/2/p38 MAPK signal pathway[J].Tumour Biol,2016,37(4):4493

[16]Oikawa T, Nakamura A, Onishi N, et al. Acquired expression of NFATc1 downregulates E-cadherin and promotes Cancer cell invasion[J].Cancer Res,2013,73(16):5100

[17]Pham L V, Tamayo A T, Li C, et al. An epigenetic chromatin remodeling role for NFATc1 in transcriptional regulation of growth and survival genes in diffuse large B-cell lymphomas[J].Blood,2010,116(19):3899

[18]Oikawa T, Oyama M, Kozuka-Hata H, et al. Tks5-dependent formation of circumferential podosomes/invadopodia mediates cell-cell fusion[J].J Cell Biol,2012,197(4):553

[19]Im J Y, Lee K W, Won K J, et al. NFATc1 regulates the transcription of DNA damage-induced apoptosis suppressor[J].Data brief, 2015,5:975

相似文献/References:

[1]梁绍平,王华庆.盐酸埃克替尼治疗晚期非小细胞肺癌的临床疗效观察[J].天津医科大学学报,2015,21(03):51.
　LIANG Shao-ping,WANG Hua-qing.Clinical observation of icotinib hydrochloride in the treatment of advanced non-small cell lung cancer[J].Journal of Tianjin Medical University,2015,21(05):51.
[2]梁绍平,王华庆.盐酸埃克替尼治疗晚期非小细胞肺癌的临床疗效观察[J].天津医科大学学报,2015,21(01):51.
　LIANG Shao-ping WANG Hua-qing.Clinical observation of icotinib hydrochloride in the treatment of advanced non-small cell lung cancer[J].Journal of Tianjin Medical University,2015,21(05):51.
[3]黄晓莹.MRI与CT在非小细胞肺癌淋巴结转移诊断中的应用价值比较[J].天津医科大学学报,2017,23(06):542.
　HUANG Xiao-ying.Application value of MRI and CT in the diagnosis of lymph node metastasis of non-small cell lung cancer[J].Journal of Tianjin Medical University,2017,23(05):542.
[4]高会霞,王 彬,方 黎,等.3DCRT联合化疗对晚期NSCLC患者近期疗效及血清肿瘤标记物的影响[J].天津医科大学学报,2019,25(05):507.
[5]王红军,贾金广,朱婉凌,等.CXCL-14在非小细胞肺癌中的表达水平及临床意义[J].天津医科大学学报,2021,27(02):112.
　WANG Hong-jun,JIA Jin-guang,ZHU Wan-ling,et al.The expression level and clinical significance of CXCL-14 in non-small cell lung cancer[J].Journal of Tianjin Medical University,2021,27(05):112.
[6]张萌,孟昭婷,张翠翠,等.Super-ARMS法检测EGFR突变在NSCLC的临床应用[J].天津医科大学学报,2021,27(02):185.
　ZHANG Meng,MENG Zhao-ting,ZHANG Cui-cui,et al.Clinical application of EGFR mutation in NSCLC detect by the way of Super-arms[J].Journal of Tianjin Medical University,2021,27(05):185.
[7]严一杰,张军,王硕,等.125I粒子植入的靶区勾画对一线治疗后局部进展的非小细胞肺癌治疗效果影响[J].天津医科大学学报,2021,27(06):586.
　YAN Yi-jie,ZHANG Jun,WANG Shuo,et al.Effect of target delineation of 125I seed implantation on the treatment of locally advanced non-small cell lung cancer after first-line therapy[J].Journal of Tianjin Medical University,2021,27(05):586.
[8]陈嫱,英硕,李冠华,等.非小细胞肺癌M1期患者的危险、预后因素和转移特征：一项基于SEER数据库的研究[J].天津医科大学学报,2022,28(01):27.
　CHEN Qiang,YING Shuo,LI Guan-hua,et al.The risk，prognostic factors and metastatic features for patients with M1 stage of non-small cell lung cancer: a SEER-based study[J].Journal of Tianjin Medical University,2022,28(05):27.
[9]张静怡,迟航,杨鑫,等.Ras相关区域家族10蛋白在非小细胞肺癌中的表达及预后价值[J].天津医科大学学报,2024,30(05):385.[doi:10.20135/j.issn.1006-8147.2024.05.0385]
　ZHANG Jingyi,CHI Hang,YANG Xin,et al.The expression and prognostic value of ras-association domain family 10 in non-small cell lung cancer[J].Journal of Tianjin Medical University,2024,30(05):385.[doi:10.20135/j.issn.1006-8147.2024.05.0385]

备注/Memo

备注/Memo:
基金项目国家自然科学基金资助项目（81573231）；天津市自然科学基金资助项目（13JCYBJC23100）

作者简介 李晶鑫（1988-），女，硕士在读，研究方向：肺癌病因学及分子流行病学；通信作者：钱碧云，E-mail：qianbiyun@126.com。

?

更新日期/Last Update: 2016-09-20